{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T04:38:38Z","timestamp":1768451918321,"version":"3.49.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","surgical.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Clinics of North America"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.suc.2016.07.010","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T02:32:49Z","timestamp":1479349969000},"page":"1371-1389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Management of Locally Advanced Pancreatic Cancer"],"prefix":"10.1016","volume":"96","author":[{"suffix":"II","given":"Robert C.G.","family":"Martin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.suc.2016.07.010_bib1","first-page":"486","article-title":"Long-term survival in metastatic pancreatic cancer. A case report and review of the literature","volume":"7","author":"Spinelli","year":"2006","journal-title":"JOP"},{"issue":"1","key":"10.1016\/j.suc.2016.07.010_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3322\/canjclin.52.1.23","article-title":"Cancer statistics, 2002","volume":"52","author":"Jemal","year":"2002","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"10.1016\/j.suc.2016.07.010_bib3","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1245\/s10434-009-0408-6","article-title":"Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement","volume":"16","author":"Callery","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.suc.2016.07.010_bib4","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1245\/ASO.2006.08.011","article-title":"Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy","volume":"13","author":"Varadhachary","year":"2006","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.suc.2016.07.010_bib5","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s002689900603","article-title":"Adjuvant therapy for pancreatic cancer","volume":"23","author":"Ghaneh","year":"1999","journal-title":"World J Surg"},{"key":"10.1016\/j.suc.2016.07.010_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1756-8722-4-11","article-title":"A\u00a0meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma","volume":"4","author":"Hu","year":"2011","journal-title":"J\u00a0Hematol Oncol"},{"issue":"31","key":"10.1016\/j.suc.2016.07.010_bib7","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1200\/JCO.2011.34.8904","article-title":"Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial","volume":"29","author":"Loehrer","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"19","key":"10.1016\/j.suc.2016.07.010_bib8","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.suc.2016.07.010_bib9","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1200\/JCO.2006.07.5663","article-title":"Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies","volume":"25","author":"Huguet","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.suc.2016.07.010_bib10","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.gassur.2004.09.026","article-title":"Is there a role for staging laparoscopy in patients with locally advanced, unresectable pancreatic adenocarcinoma?","volume":"8","author":"Shoup","year":"2004","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"5","key":"10.1016\/j.suc.2016.07.010_bib11","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s00464-004-8165-x","article-title":"Diagnostic laparoscopy improves staging of pancreatic cancer deemed locally unresectable by computed tomography","volume":"19","author":"Liu","year":"2005","journal-title":"Surg Endosc"},{"issue":"1","key":"10.1016\/j.suc.2016.07.010_bib12","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1148\/radiol.13131184","article-title":"Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association","volume":"270","author":"Al-Hawary","year":"2014","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.suc.2016.07.010_bib13","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1245\/s10434-014-4225-1","article-title":"Neoadjuvant modified (m) FOLFIRINOX for locally advanced unresectable (LAPC) and borderline resectable (BRPC) adenocarcinoma of the pancreas","volume":"22","author":"Blazer","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"18","key":"10.1016\/j.suc.2016.07.010_bib14","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 7","key":"10.1016\/j.suc.2016.07.010_bib15","doi-asserted-by":"crossref","first-page":"vii33","DOI":"10.1093\/annonc\/mds224","article-title":"Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"23","author":"Seufferlein","year":"2012","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.suc.2016.07.010_bib16","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1046\/j.1532-5415.2001.49281.x","article-title":"The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community","volume":"49","author":"Saliba","year":"2001","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"3","key":"10.1016\/j.suc.2016.07.010_bib17","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11605-013-2443-7","article-title":"Value of geriatric frailty and nutritional status assessment in predicting postoperative mortality in gastric cancer surgery","volume":"18","author":"Tegels","year":"2014","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"8","key":"10.1016\/j.suc.2016.07.010_bib18","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1200\/JCO.2004.10.112","article-title":"Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer","volume":"22","author":"Van Cutsem","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"18","key":"10.1016\/j.suc.2016.07.010_bib19","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1200\/JCO.2004.12.082","article-title":"Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate","volume":"22","author":"Rocha Lima","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.suc.2016.07.010_bib20","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/jjco\/hyq011","article-title":"Phase II study of gemcitabine chemotherapy alone for locally advanced pancreatic carcinoma: JCOG0506","volume":"40","author":"Ishii","year":"2010","journal-title":"Jpn J Clin Oncol"},{"issue":"5","key":"10.1016\/j.suc.2016.07.010_bib21","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1245\/s10434-011-2110-8","article-title":"Neoadjuvant\/preoperative gemcitabine for patients with localized pancreatic cancer: a meta-analysis of prospective studies","volume":"19","author":"Andriulli","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.suc.2016.07.010_bib22","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1245\/s10434-014-3486-z","article-title":"Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival","volume":"21","author":"Rose","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.suc.2016.07.010_bib23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/jamasurg.2013.2690","article-title":"Locally advanced pancreatic cancer: association between prolonged preoperative treatment and lymph-node negativity and overall survival","volume":"149","author":"Kadera","year":"2014","journal-title":"JAMA Surg"},{"issue":"1","key":"10.1016\/j.suc.2016.07.010_bib24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/SLA.0000000000000867","article-title":"Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer","volume":"261","author":"Ferrone","year":"2015","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.suc.2016.07.010_bib25","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.surg.2014.06.058","article-title":"Borderline and locally advanced pancreatic adenocarcinoma margin accentuation with intraoperative irreversible electroporation","volume":"156","author":"Kwon","year":"2014","journal-title":"Surgery"},{"issue":"3","key":"10.1016\/j.suc.2016.07.010_bib26","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/SLA.0000000000001441","article-title":"Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy","volume":"262","author":"Martin","year":"2015","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.suc.2016.07.010_bib27","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/jso.23392","article-title":"Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer","volume":"108","author":"Boone","year":"2013","journal-title":"J\u00a0Surg Oncol"},{"issue":"10","key":"10.1016\/j.suc.2016.07.010_bib28","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1007\/s11605-013-2309-z","article-title":"Irreversible electroporation of locally advanced pancreatic head adenocarcinoma","volume":"17","author":"Martin","year":"2013","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"3","key":"10.1016\/j.suc.2016.07.010_bib29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.surg.2010.07.048","article-title":"NeoGemOx: Gemcitabine and oxaliplatin as neoadjuvant treatment for locally advanced, nonmetastasized pancreatic cancer","volume":"149","author":"Sahora","year":"2011","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.suc.2016.07.010_bib30","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ijrobp.2005.07.002","article-title":"Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer","volume":"63","author":"Koong","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.suc.2016.07.010_bib31","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s11605-010-1323-7","article-title":"Image-guided stereotactic radiosurgery for locally advanced pancreatic adenocarcinoma results of first 85 patients","volume":"14","author":"Didolkar","year":"2010","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"1","key":"10.1016\/j.suc.2016.07.010_bib32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.radonc.2004.12.022","article-title":"Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma","volume":"76","author":"Hoyer","year":"2005","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.suc.2016.07.010_bib33","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/cncr.24059","article-title":"Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas","volume":"115","author":"Chang","year":"2009","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.suc.2016.07.010_bib34","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ijrobp.2008.01.051","article-title":"Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer","volume":"72","author":"Schellenberg","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.suc.2016.07.010_bib35","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.ijrobp.2004.12.074","article-title":"A\u00a0randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282","volume":"62","author":"Cohen","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.suc.2016.07.010_bib36","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/sj.bjc.6603719","article-title":"Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation\/combined modality therapy","volume":"96","author":"Sultana","year":"2007","journal-title":"Br J Cancer"},{"issue":"13","key":"10.1016\/j.suc.2016.07.010_bib37","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1200\/JCO.2008.19.7921","article-title":"Chemoradiotherapy in the management of locally advanced pancreatic carcinoma: a qualitative systematic review","volume":"27","author":"Huguet","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.suc.2016.07.010_bib38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/cncr.22735","article-title":"Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy","volume":"110","author":"Krishnan","year":"2007","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.suc.2016.07.010_bib39","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1002\/cncr.26633","article-title":"Long-term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancer","volume":"118","author":"Arvold","year":"2012","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.suc.2016.07.010_bib40","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/archsurg.2011.152","article-title":"Downstaging chemotherapy and alteration in the classic computed tomography\/magnetic resonance imaging signs of vascular involvement in patients with pancreaticobiliary malignant tumors: influence on patient selection for surgery","volume":"146","author":"Donahue","year":"2011","journal-title":"Arch Surg"},{"issue":"9","key":"10.1016\/j.suc.2016.07.010_bib41","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1245\/s10434-006-9032-x","article-title":"Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival","volume":"13","author":"Massucco","year":"2006","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.suc.2016.07.010_bib42","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.ejso.2009.06.005","article-title":"Neoadjuvant chemoradiation and pancreaticoduodenectomy for initially locally advanced head pancreatic adenocarcinoma","volume":"35","author":"Turrini","year":"2009","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.suc.2016.07.010_bib43","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.gie.2005.10.034","article-title":"EUS-guided alcohol ablation of an insulinoma","volume":"63","author":"Jurgensen","year":"2006","journal-title":"Gastrointest Endosc"},{"issue":"7","key":"10.1016\/j.suc.2016.07.010_bib44","doi-asserted-by":"crossref","first-page":"074003","DOI":"10.1115\/1.3156804","article-title":"Adjuvant approaches to enhance cryosurgery","volume":"131","author":"Goel","year":"2009","journal-title":"J\u00a0Biomech Eng"},{"issue":"1","key":"10.1016\/j.suc.2016.07.010_bib45","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1006\/cryo.2001.2312","article-title":"Two freezing cycles ensure interface sterilization by cryosurgery during bone tumor resection","volume":"43","author":"Robinson","year":"2001","journal-title":"Cryobiology"},{"issue":"1","key":"10.1016\/j.suc.2016.07.010_bib46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00423-006-0098-5","article-title":"Radiofrequency ablation combined with palliative surgery may prolong survival of patients with advanced cancer of the pancreas","volume":"392","author":"Spiliotis","year":"2007","journal-title":"Langenbecks Arch Surg"},{"issue":"6","key":"10.1016\/j.suc.2016.07.010_bib47","first-page":"588","article-title":"Radiofrequency ablation of the pancreas. II: Intra-operative ablation of non-resectable pancreatic cancer. A description of technique and initial outcome","volume":"6","author":"Date","year":"2005","journal-title":"JOP"},{"issue":"1","key":"10.1016\/j.suc.2016.07.010_bib48","first-page":"1","article-title":"Radiofrequency ablation for locally advanced cancer of the pancreas","volume":"7","author":"Siriwardena","year":"2006","journal-title":"JOP"},{"issue":"1","key":"10.1016\/j.suc.2016.07.010_bib49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/jso.21899","article-title":"Irreversible electroporation of the pancreas: definitive local therapy without systemic effects","volume":"104","author":"Bower","year":"2011","journal-title":"J\u00a0Surg Oncol"},{"issue":"1-2","key":"10.1016\/j.suc.2016.07.010_bib50","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1615\/CritRevBiomedEng.v35.i1-2.20","article-title":"Thermal therapy, part III: ablation techniques","volume":"35","author":"Habash","year":"2007","journal-title":"Crit Rev Biomed Eng"},{"issue":"5","key":"10.1016\/j.suc.2016.07.010_bib51","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1477-2574.2010.00174.x","article-title":"Irreversible electroporation of the pancreas in swine: a pilot study","volume":"12","author":"Charpentier","year":"2010","journal-title":"HPB (Oxford)"},{"issue":"9","key":"10.1016\/j.suc.2016.07.010_bib52","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/bjs.9536","article-title":"Evaluation of thermal injury to liver, pancreas and kidney during irreversible electroporation in an in\u00a0vivo experimental model","volume":"101","author":"Dunki-Jacobs","year":"2014","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.suc.2016.07.010_bib53","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10439-005-8981-8","article-title":"Tissue ablation with irreversible electroporation","volume":"33","author":"Davalos","year":"2005","journal-title":"Ann Biomed Eng"},{"issue":"11","key":"10.1016\/j.suc.2016.07.010_bib54","doi-asserted-by":"crossref","first-page":"e1135","DOI":"10.1371\/journal.pone.0001135","article-title":"Tumor ablation with irreversible electroporation","volume":"2","author":"Al-Sakere","year":"2007","journal-title":"PLoS One"},{"issue":"23-24","key":"10.1016\/j.suc.2016.07.010_bib55","doi-asserted-by":"crossref","first-page":"5610","DOI":"10.1016\/j.ijheatmasstransfer.2008.04.041","article-title":"Mass transfer model for drug delivery in tissue cells with reversible electroporation","volume":"51","author":"Granot","year":"2008","journal-title":"Int J Heat\u00a0Mass\u00a0Transf"},{"issue":"11","key":"10.1016\/j.suc.2016.07.010_bib56","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1177\/0091270009344984","article-title":"Electroporation as an efficient physical enhancer for skin drug delivery","volume":"49","author":"Escobar-Chavez","year":"2009","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.suc.2016.07.010_bib57","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2174\/156652306776359504","article-title":"Electroporation-enhanced nonviral gene transfer for the prevention or treatment of immunological, endocrine and neoplastic diseases","volume":"6","author":"Prud'homme","year":"2006","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.suc.2016.07.010_bib58","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1196\/annals.1363.007","article-title":"Cell injury by electric forces","volume":"1066","author":"Lee","year":"2005","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.suc.2016.07.010_bib59","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/153303460700600106","article-title":"Irreversible electroporation: a new ablation modality\u2013clinical implications","volume":"6","author":"Rubinsky","year":"2007","journal-title":"Technol Cancer Res Treat"},{"issue":"7","key":"10.1016\/j.suc.2016.07.010_bib60","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1109\/TBME.2006.873745","article-title":"In\u00a0vivo results of a new focal tissue ablation technique: irreversible electroporation","volume":"53","author":"Edd","year":"2006","journal-title":"IEEE Trans Biomed Eng"},{"issue":"4","key":"10.1016\/j.suc.2016.07.010_bib61","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/153303460700600407","article-title":"The effect of irreversible electroporation on blood vessels","volume":"6","author":"Maor","year":"2007","journal-title":"Technol Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.suc.2016.07.010_bib62","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jamcollsurg.2013.10.013","article-title":"Evaluation of resistance as a measure of successful tumor ablation during irreversible electroporation of the pancreas","volume":"218","author":"Dunki-Jacobs","year":"2014","journal-title":"J\u00a0Am Coll Surg"},{"issue":"3","key":"10.1016\/j.suc.2016.07.010_bib63","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jamcollsurg.2012.05.021","article-title":"Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma","volume":"215","author":"Martin","year":"2012","journal-title":"J\u00a0Am Coll Surg"},{"issue":"Suppl 3","key":"10.1016\/j.suc.2016.07.010_bib64","doi-asserted-by":"crossref","first-page":"S443","DOI":"10.1245\/s10434-012-2736-1","article-title":"Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival","volume":"20","author":"Martin","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2016.07.010_bib65","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/SLA.0000000000001441","article-title":"Treatment of 200 locally advanced (Stage III) pancreatic adenocarcinoma patients with irreversible electroporation safety and efficacy","volume":"262","author":"Martin","year":"2015","journal-title":"Ann Surg"},{"issue":"12","key":"10.1016\/j.suc.2016.07.010_bib66","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.jvir.2012.09.012","article-title":"Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma","volume":"23","author":"Narayanan","year":"2012","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.suc.2016.07.010_bib67","doi-asserted-by":"crossref","first-page":"15001","DOI":"10.1038\/mtm.2015.1","article-title":"Efficacy of irreversible electroporation in human pancreatic adenocarcinoma: advanced murine model","volume":"2","author":"Philips","year":"2015","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"3","key":"10.1016\/j.suc.2016.07.010_bib68","first-page":"329","article-title":"Irreversible electroporation in locally advanced pancreatic adenocarcinoma of body\/neck","volume":"6","author":"Martin","year":"2015","journal-title":"J\u00a0Gastrointest Oncol"},{"issue":"3","key":"10.1016\/j.suc.2016.07.010_bib69","first-page":"211","article-title":"Use of irreversible electroporation in unresectable pancreatic cancer","volume":"4","author":"Martin","year":"2015","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"11","key":"10.1016\/j.suc.2016.07.010_bib70","doi-asserted-by":"crossref","first-page":"e76260","DOI":"10.1371\/journal.pone.0076260","article-title":"Irreversible electroporation ablation (IRE) of unresectable soft tissue tumors: learning curve evaluation in the first 150 patients treated","volume":"8","author":"Philips","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.suc.2016.07.010_bib71","first-page":"680319","article-title":"CT findings of patients treated with irreversible electroporation for locally advanced pancreatic cancer","volume":"2015","author":"Akinwande","year":"2015","journal-title":"J\u00a0Oncol"}],"container-title":["Surgical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610916520519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610916520519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T17:29:56Z","timestamp":1568568596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039610916520519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":71,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0039610916520519"],"URL":"https:\/\/doi.org\/10.1016\/j.suc.2016.07.010","relation":{},"ISSN":["0039-6109"],"issn-type":[{"value":"0039-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Locally Advanced Pancreatic Cancer","name":"articletitle","label":"Article Title"},{"value":"Surgical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suc.2016.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}